Core Viewpoint - Treace Medical Concepts, Inc. (NASDAQ: TMCI) is facing a class action lawsuit due to allegations of issuing materially false and misleading statements regarding its primary product, the 3D bunion correction system, "Lapiplasty" [3]. Summary by Relevant Sections Class Period and Allegations - The class period for the lawsuit is from May 8, 2023, to May 7, 2024 [3]. - Allegations include that competition negatively impacted the demand for the Lapiplasty system, leading to a decline in Treace Medical's revenue [3]. - The company needed to accelerate plans for an alternative product to osteotomy due to these challenges [3]. - Defendants' positive statements about the company's business and prospects were claimed to be materially misleading [3]. Next Steps for Shareholders - Shareholders are encouraged to register for the class action by June 10, 2025, to participate in potential recovery [4]. - Registration will include enrollment in a portfolio monitoring software for status updates throughout the case [4]. Law Firm Information - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [5]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [5].

Core Viewpoint - The Gross Law Firm is notifying shareholders of Napco Security Technologies, Inc. regarding a class action lawsuit due to alleged misleading statements about the company's growth and hardware sales performance [1][2]. Summary by Relevant Sections Allegations - The complaint alleges that Napco's management provided investors with optimistic projections about the company's growth and strength in its hardware division, claiming confidence in achieving fiscal 2026 growth targets based on demand forecasts [1]. - On February 3, 2025, Napco reported a significant decline in hardware sales, attributing this primarily to reduced sales from two major distributors, leading to a retraction of their long-term 45% EBITDA margin target [1]. Stock Performance - Following the announcement of disappointing financial results, Napco's stock price fell from $36.70 per share on January 31, 2024, to $26.93 per share on February 3, 2025, marking a decline of approximately 26.62% in one day [1]. Class Action Details - Shareholders who purchased shares during the specified class period (February 5, 2024, to February 3, 2025) are encouraged to register for the class action, with a deadline for lead plaintiff applications set for June 24, 2025 [2]. - Participants will be enrolled in a portfolio monitoring system to receive updates on the case's progress [2]. Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud, aiming to hold companies accountable for misleading practices that inflate stock prices [3].

Core Viewpoint - A class action lawsuit has been filed against Napco Security Technologies, Inc. for alleged violations of federal securities laws, particularly concerning misleading statements about growth projections and sales performance [1][2]. Group 1: Lawsuit Details - The lawsuit pertains to shareholders who purchased Napco's securities between February 5, 2024, and February 3, 2025 [1]. - The complaint claims that Napco made false statements regarding its confidence in growth projections based on customer demand for hardware products [2]. - Napco's financial results for the second quarter, announced on February 3, 2025, showed a decline in hardware product sales, contradicting previous optimistic statements [2]. Group 2: Financial Performance - The company attributed the sales shortfall to reduced sales from two of its larger distributors [2]. - Following the disappointing sales results, Napco retracted its long-term EBITDA margin target of 45%, stating uncertainty about its achievability [2].

Core Viewpoint - The Gross Law Firm is notifying shareholders of Strategy Incorporated (NASDAQ: MSTR) about a class action lawsuit due to alleged misleading statements regarding the company's bitcoin investment strategy and treasury operations [1][2]. Group 1: Allegations - The complaint claims that during the class period from April 30, 2024, to April 4, 2025, the defendants made materially false and misleading statements [2]. - It is alleged that the anticipated profitability of the company's bitcoin-focused investment strategy was overstated [2]. - The risks associated with bitcoin's volatility and potential losses from digital assets were understated, leading to misleading public statements [2]. Group 2: Class Action Details - The deadline for shareholders to register for the class action is July 15, 2025 [3]. - Shareholders who register will be enrolled in a portfolio monitoring software for status updates throughout the case [3]. - There is no cost or obligation for shareholders to participate in the case [3]. Group 3: Law Firm's Mission - The Gross Law Firm aims to protect the rights of investors affected by deceit and illegal business practices [4]. - The firm is committed to ensuring companies adhere to responsible business practices and good corporate citizenship [4]. - The firm seeks recovery for investors who suffered losses due to false or misleading statements that inflated the company's stock [4].

URGN Investors with Losses Encouraged to Contact Hagens BermanSAN FRANCISCO, May 29, 2025 /PRNewswire/ -- On May 21, 2025, investors in UroGen Pharma Ltd. (NASDAQ: URGN) saw the price of their shares crash 44% after the company announced that the FDA's Oncologic Drugs Advisory Committee ("ODAC") voted against the risk/benefit profile of UroGen's UGN-102, a therapy intended to treat patients with low-grade, intermediate-risk non-muscle invasive bladder cancer ("LG-IR-NMIBC") for which no drugs are currently ...

Core Points - The Gross Law Firm has issued a notice to shareholders of Ibotta, Inc. regarding a class action lawsuit related to the company's initial public offering on April 18, 2024 [1][3] - The lawsuit alleges that Ibotta made false statements and failed to disclose the risks associated with its contract with Kroger, specifically that the contract was at-will and could be terminated without warning [4] - Shareholders are encouraged to register for the class action by June 16, 2025, to potentially become lead plaintiffs and receive updates on the case [5] Company and Industry Summary - Ibotta, Inc. is facing legal challenges due to allegations of misleading investors about the nature of its contract with Kroger, which could impact investor confidence and stock performance [4] - The Gross Law Firm aims to protect investors' rights and seeks recovery for those who suffered losses due to misleading statements from companies like Ibotta [6]

NEW YORK, May 29, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Viatris Inc. (NASDAQ: VTRS).Shareholders who purchased shares of VTRS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/viatris-inc-loss-submission-form-2/?id=150490&from=4CLASS PERIOD: August 8, 2024 to February ...

Core Viewpoint - A lawsuit has been filed against The Bancorp, Inc. (NASDAQ: TBBK) by an investor, alleging violations of securities laws related to undisclosed risks and financial reporting issues [2]. Group 1: Lawsuit Details - The lawsuit claims that The Bancorp underrepresented the significant risk of default or loss on its REBL loan portfolio [2]. - Allegations include that the company's expected credit loss methodology was insufficient, leading to a likely increase in provisions for credit losses [2]. - The plaintiff asserts there were material weaknesses in internal controls over financial reporting, and that financial statements were not approved by an independent auditor, making them unreliable [2]. Group 2: Investor Information - Shareholders who purchased shares of The Bancorp, Inc. prior to February 2024 and continue to hold them are encouraged to contact the Shareholders Foundation for options [1][3]. - The Shareholders Foundation provides services related to shareholder issues, including information on securities class actions and legal news [3].

Core Viewpoint - A class action lawsuit has been filed against Open Lending Corporation for alleged violations of federal securities laws, specifically regarding misleading statements about its risk-based pricing model and profit share revenue [1] Group 1: Lawsuit Details - The lawsuit claims that Open Lending overstated the capabilities of its risk-based pricing model and misrepresented its profit share revenue [1] - It is alleged that the company failed to disclose that loans from 2021 and 2022 were worth less than their outstanding balances [1] - Investors were misled about the underperformance of the company's vintage loans from 2023 and 2024 [1] Group 2: Shareholder Information - Shareholders who purchased Open Lending securities between February 24, 2022, and March 31, 2025, are encouraged to contact the DJS Law Group before June 30, 2025, to participate in the lawsuit [1][2]

SAN FRANCISCO, May 22, 2025 (GLOBE NEWSWIRE) -- On May 21, 2025, investors in UroGen Pharma Ltd. (NASDAQ: URGN) saw the price of their shares crash 44% after the company announced that the FDA’s Oncologic Drugs Advisory Committee (“ODAC”) voted against the risk/benefit profile of UroGen’s UGN-102, a therapy intended to treat patients with low-grade, intermediate-risk non-muscle invasive bladder cancer (“LG-IR-NMIBC”) for which no drugs are currently FDA-approved. Hagens Berman has opened an investigation in ...